Evidence map›Paper›PMID 35871361›Full record

ReviewJournal of Huntington's disease2022

Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.

Srinivasa Subramaniam

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of Huntington's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Srinivasa SubramaniamDepartment of Neuroscience, UF Scripps Biomedical Research, Jupiter, FL, USA.
Scripps (United States) · US

Funding

mTOR Signaling in Striatum: Regulation and FunctionR01NS087019 · NINDS · SCRIPPS FLORIDA · PI SUBRAMANIAM, SRINI · 2015 to 2019
$2.3M
Rhes-SUMO circuitry in Huntington's Disease PathogenesisR01NS094577 · NINDS · SCRIPPS FLORIDA · PI SUBRAMANIAM, SRINI · 2016 to 2019
$1.7M
NINDS NIH HHS R01 NS087019NINDS NIH HHS R01 NS094577
6 · The paper itself

Abstract

The CAG/CAA expansion encoding polyQ huntingtin (mutant huntingtin [mHTT]) causes Huntington's disease (HD), which is characterized by atrophy and loss of striatal medium spiny neurons (MSNs), which are preceded by neuropathological alterations in the cortex. Previous studies have shown that mHTT can spread in the brain, but the mechanisms involved in the stereotyped degeneration and dysfunction of the neurons from the striatum to the cortex remain unclear. In this study, we found that the mHTT expression initially restricted in the striatum later spread to the cortical regions in mouse brains. Such transmission was diminished in mice that lacked the striatal-enriched protein Ras-homolog enriched in the striatum (Rhes). Rhes restricted to MSNs was also found in the cortical layers of the brain, indicating a new transmission route for the Rhes protein to the brain. Mechanistically, Rhes promotes such transmission via a direct cell-to-cell contact mediated by tunneling nanotubes (TNTs), the membranous protrusions that enable the transfer of mHTT, Rhes, and other vesicular cargoes. These transmission patterns suggest that Rhes and mHTT are likely co-transported in the brain using TNT-like cell-to-cell contacts. On the basis of these new results, a perspective is presented in this review: Rhes may ignite the mHTT transmission from the striatum that may coincide with HD onset and disease progression through an anatomically connected striato-cortical retrograde route.

Indexed as

Huntington DiseaseAnimalsCorpus StriatumDisease Models, AnimalGTP-Binding ProteinsHuntingtin ProteinMiceNeostriatumNeuronsGTP-Binding ProteinsHuntingtin ProteinCortico-striatal pathwayneurodegenerationneuronal vulnerabilityprotein spreadingretrograde signalingtunneling nanotubes

Identifiers

PMID35871361
PMCPMC9484121
OpenAlexW4285801451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.